Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2016 (2016), Article ID 7527098, 4 pages
http://dx.doi.org/10.1155/2016/7527098
Case Report

A Possible Association of Diindolylmethane with Pulmonary Embolism and Deep Venous Thrombosis

1Department of Internal Medicine, University of New Mexico, Albuquerque, NM, USA
2West Houston Medical Center, Hospital Corporation of America, Houston, TX, USA
3Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, Raymond G. Murphy VA Medical Center, Albuquerque, NM, USA
4Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of New Mexico, Albuquerque, NM, USA

Received 3 July 2016; Revised 1 November 2016; Accepted 16 November 2016

Academic Editor: Christos D. Lionis

Copyright © 2016 Peter V. Bui et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. H. White, “The epidemiology of venous thromboembolism,” Circulation, vol. 107, no. 23, pp. I-4–I-8, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. J. A. Heit, D. N. Mohr, M. D. Silverstein, T. M. Petterson, W. M. O'Fallon, and L. J. Melton III, “Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study,” Archives of Internal Medicine, vol. 160, no. 6, pp. 761–768, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. Y.-J. Cheng, Z.-H. Liu, F.-J. Yao et al., “Current and former smoking and risk for venous thromboembolism: a systematic review and meta-analysis,” PLoS Medicine, vol. 10, no. 9, Article ID e1001515, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Cushman, “Epidemiology and risk factors for venous thrombosis,” Seminars in Hematology, vol. 44, no. 2, pp. 62–69, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. K. F. Enga, S. K. Brækkan, I. J. Hansen-Krone, S. Le Cessie, F. R. Rosendaal, and J.-B. Hansen, “Cigarette smoking and the risk of venous thromboembolism: the Tromsø Study,” Journal of Thrombosis and Haemostasis, vol. 10, no. 10, pp. 2068–2074, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. A. G. Holst, G. Jensen, and E. Prescott, “Risk factors for venous thromboembolism: results from the copenhagen city heart study,” Circulation, vol. 121, no. 17, pp. 1896–1903, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. T. Severinsen, S. R. Kristensen, S. P. Johnsen, C. Dethlefsen, A. Tjønneland, and K. Overvad, “Smoking and venous thromboembolism: a Danish follow-up study,” Journal of Thrombosis and Haemostasis, vol. 7, no. 8, pp. 1297–1303, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Eisenberger and C. Westhoff, “Hormone replacement therapy and venous thromboembolism,” Journal of Steroid Biochemistry and Molecular Biology, vol. 142, pp. 76–82, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. I. Chen, T. Hsieh, T. Thomas, and S. Safe, “Identification of estrogen-induced genes downregulated by AhR agonists in MCF-7 breast cancer cells using suppression subtractive hybridization,” Gene, vol. 262, no. 1-2, pp. 207–214, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Chen, S. Safe, and L. Bjeldanes, “Indole-3-carbinol and diindolylmethane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells,” Biochemical Pharmacology, vol. 51, no. 8, pp. 1069–1076, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Mulvey, A. Chandrasekaran, K. Liu et al., “Interplay of genes regulated by estrogen and diindolylmethane in breast cancer cell lines,” Molecular Medicine, vol. 13, no. 1-2, pp. 69–78, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. J. E. Riby, G. H. F. Chang, G. L. Firestone, and L. F. Bjeldanes, “Ligand-independent activation of estrogen receptor function by 3,3′-diindolylmethane in human breast cancer cells,” Biochemical Pharmacology, vol. 60, no. 2, pp. 167–177, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Castañon, A. Tristram, D. Mesher et al., “Effect of diindolylmethane supplementation on low-grade cervical cytological abnormalities: double-blind, randomised, controlled trial,” British Journal of Cancer, vol. 106, no. 1, pp. 45–52, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. K. J. Auborn, S. Fan, E. M. Rosen et al., “Indole-3-carbinol is a negative regulator of estrogen,” Journal of Nutrition, vol. 133, no. 7, supplement, pp. 2470S–2475S, 2003. View at Google Scholar · View at Scopus
  15. H. Liu, M. Wormke, S. H. Safe, and L. F. Bjeldanes, “Indolo[3,2-b]carbazole: a dietary-derived factor that exhibits both antiestrogenic and estrogenic activity,” Journal of the National Cancer Institute, vol. 86, no. 23, pp. 1758–1765, 1994. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Ohtake, K.-I. Takeyama, T. Matsumoto et al., “Modulation of oestrogen receptor signalling by association with the activated dioxin receptor,” Nature, vol. 423, no. 6939, pp. 545–550, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. H. T. Le, C. M. Schaldach, G. L. Firestone, and L. F. Bjeldanes, “Plant-derived 3,3′-diindolylmethane is a strong androgen antagonist in human prostate cancer cells,” The Journal of Biological Chemistry, vol. 278, no. 23, pp. 21136–21145, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. S. N. Tchaikovski and J. Rosing, “Mechanisms of estrogen-induced venous thromboembolism,” Thrombosis Research, vol. 126, no. 1, pp. 5–11, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. J. P. Vandenbroucke, T. Koster, E. Briët, P. H. Reitsma, R. M. Bertina, and F. R. Rosendaal, “Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation,” Lancet, vol. 344, no. 8935, pp. 1453–1457, 1994. View at Publisher · View at Google Scholar · View at Scopus